Annals of Oncology

in this issue:

in this issue
Ann Oncol 17: 1179; doi:10.1093/annonc/mdl293
[Extract] [Full Text] [PDF] [Request Permissions]

editorial:

P. S. Hupperets and V. C. Tjan-Heijnen

Primary or secondary G-CSF prophylaxis to support TAC chemotherapy in breast cancer?
Ann Oncol 17: 1181-1183; doi:10.1093/annonc/mdl292
[Extract] [Full Text] [PDF] [Request Permissions]

reviews:

P. Schöffski, H. Dumez, P. Clement, A. Hoeben, H. Prenen, P. Wolter, S. Joniau, T. Roskams, and H. Van Poppel

Emerging role of tyrosine kinase inhibitors in the treatment of advanced renal cell cancer: a review
Annals of Oncology Advance Access published on January 17, 2006
Ann Oncol 17: 1185-1196; doi:10.1093/annonc/mdj133
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

T. Van den Wyngaert, M. T. Huizing, and J. B. Vermorken

Bisphosphonates and osteonecrosis of the jaw: cause and effect or a post hoc fallacy?
Ann Oncol 17: 1197-1204; doi:10.1093/annonc/mdl294
[Abstract] [FREE Full Text] [PDF] [Request Permissions]

original articles:

breast cancer:

M. Martín, A. Lluch, M. A. Seguí, A. Ruiz, M. Ramos, E. Adrover, Á. Rodríguez-Lescure, R. Grosse, L. Calvo, C. Fernandez-Chacón, M. Roset, A. Antón, D. Isla, P. Martínez del Prado, L. Iglesias, J. Zaluski, A. Arcusa, J. M. López-Vega, M. Muñoz, and J. R. Mel

Toxicity and health-related quality of life in breast cancer patients receiving adjuvant docetaxel, doxorubicin, cyclophosphamide (TAC) or 5-fluorouracil, doxorubicin and cyclophosphamide (FAC): impact of adding primary prophylactic granulocyte-colony stimulating factor to the TAC regimen
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1205-1212; doi:10.1093/annonc/mdl135
[Abstract] [Full Text] [PDF] [Request Permissions]

R. Kim, M. Kaneko, K. Arihiro, M. Emi, K. Tanabe, S. Murakami, A. Osaki, and K. Inai

Extranuclear expression of hormone receptors in primary breast cancer
Annals of Oncology Advance Access published on June 7, 2006
Ann Oncol 17: 1213-1220; doi:10.1093/annonc/mdl118
[Abstract] [Full Text] [PDF] [Request Permissions]

H. Roché, P. Kerbrat, J. Bonneterre, P. Fargeot, P. Fumoleau, A. Monnier, P. Clavère, M.-J. Goudier, P. Chollet, J.-P. Guastalla, and D. Serin On behalf of the French Adjuvant Study Group

Complete hormonal blockade versus epirubicin-based chemotherapy in premenopausal, one to three node-positive, and hormone-receptor positive, early breast cancer patients: 7-year follow-up results of French Adjuvant Study Group 06 randomised trial
Annals of Oncology Advance Access published on May 26, 2006
Ann Oncol 17: 1221-1227; doi:10.1093/annonc/mdl107
[Abstract] [Full Text] [PDF] [Request Permissions]

M. Tubiana-Hulin, D. Stevens, S. Lasry, J. M. Guinebretière, L. Bouita, C. Cohen-Solal, P. Cherel, and J. Rouëssé

Response to neoadjuvant chemotherapy in lobular and ductal breast carcinomas: a retrospective study on 860 patients from one institution
Annals of Oncology Advance Access published on June 1, 2006
Ann Oncol 17: 1228-1233; doi:10.1093/annonc/mdl114
[Abstract] [Full Text] [PDF] [Request Permissions]

gynecologic tumors:

J. M. Riedinger, J. Wafflart, G. Ricolleau, N. Eche, H. Larbre, J. P. Basuyau, I. Dalifard, K. Hacene, and M. F. Pichon

CA 125 half-life and CA 125 nadir during induction chemotherapy are independent predictors of epithelial ovarian cancer outcome: results of a French multicentric study
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1234-1238; doi:10.1093/annonc/mdl120
[Abstract] [Full Text] [PDF] [Request Permissions]

gastrointestinal tumors:

R. Glynne-Jones, S. Mawdsley, T. Pearce, and M. Buyse

Alternative clinical end points in rectal cancer—are we getting closer?
Ann Oncol 17: 1239-1248; doi:10.1093/annonc/mdl173
[Abstract] [Full Text] [PDF] [Request Permissions]

G. Masi, L. Marcucci, F. Loupakis, E. Cerri, C. Barbara, S. Bursi, G. Allegrini, I. M. Brunetti, R. Murr, S. Ricci, S. Cupini, M. Andreuccetti, and A. Falcone

First-line 5-fluorouracil/folinic acid, oxaliplatin and irinotecan (FOLFOXIRI) does not impair the feasibility and the activity of second line treatments in metastatic colorectal cancer
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1249-1254; doi:10.1093/annonc/mdl119
[Abstract] [Full Text] [PDF] [Request Permissions]

lung cancer:

J. A. Zell, S.-H. I. Ou, A. Ziogas, and H. Anton-Culver

Long-term survival differences for bronchiolo-alveolar carcinoma patients with ipsilateral intrapulmonary metastasis at diagnosis
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1255-1262; doi:10.1093/annonc/mdl121
[Abstract] [Full Text] [PDF] [Request Permissions]

M. R. Green, G. M. Manikhas, S. Orlov, B. Afanasyev, A. M. Makhson, P. Bhar, and M. J. Hawkins

Abraxane^®, a novel Cremophor^®-free, albumin-bound particle form of paclitaxel for the treatment of advanced non-small-cell lung cancer
Annals of Oncology Advance Access published on June 1, 2006
Ann Oncol 17: 1263-1268; doi:10.1093/annonc/mdl104
[Abstract] [Full Text] [PDF] [Request Permissions]

A. Vergnenegre, C. Combescure, P. Fournel, S. Bayle, C. Gimenez, P. J. Souquet, H. Lena, M. Perol, and J. Y. Delhoume GFPC (Groupe Français de Pneumo-Cancérologie)

Cost-minimization analysis of a phase III trial comparing concurrent versus sequential radiochemotherapy for locally advanced non-small-cell lung cancer (GFPC-GLOT 95–01)
Annals of Oncology Advance Access published on May 25, 2006
Ann Oncol 17: 1269-1274; doi:10.1093/annonc/mdl100
[Abstract] [Full Text] [PDF] [Request Permissions]

hematologic malignancies:

O. Tournilhac, D. D. Santos, L. Xu, J. Kutok, Y.-T. Tai, S. Le Gouill, L. Catley, Z. Hunter, A. R. Branagan, J. A. Boyce, N. Munshi, K. C. Anderson, and S. P. Treon

Mast cells in Waldenstrom's macroglobulinemia support lymphoplasmacytic cell growth through CD154/CD40 signaling
Annals of Oncology Advance Access published on June 20, 2006
Ann Oncol 17: 1275-1282; doi:10.1093/annonc/mdl109
[Abstract] [Full Text] [PDF] [Request Permissions]

T. Battaglioli, G. Gorini, A. Seniori Costantini, P. Crosignani, L. Miligi, O. Nanni, E. Stagnaro, R. Tumino, and P. Vineis

Cigarette smoking and alcohol consumption as determinants of survival in non-Hodgkin's lymphoma: a population-based study
Annals of Oncology Advance Access published on May 25, 2006
Ann Oncol 17: 1283-1289; doi:10.1093/annonc/mdl096
[Abstract] [Full Text] [PDF] [Request Permissions]

O. Landgren, U. Axdorph, T. R. Fears, A. Porwit-MacDonald, C. Wedelin, and M. Björkholm

A population-based cohort study on early-stage Hodgkin lymphoma treated with radiotherapy alone: with special reference to older patients
Annals of Oncology Advance Access published on June 1, 2006
Ann Oncol 17: 1290-1295; doi:10.1093/annonc/mdl094
[Abstract] [Full Text] [PDF] [Request Permissions]

P. L. Zinzani, M. Tani, S. Fanti, L. Alinari, G. Musuraca, E. Marchi, V. Stefoni, P. Castellucci, M. Fina, M. Farshad, S. Pileri, and M. Baccarani

Early positron emission tomography (PET) restaging: a predictive final response in Hodgkin's disease patients
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1296-1300; doi:10.1093/annonc/mdl122
[Abstract] [Full Text] [PDF] [Request Permissions]

sarcomas:

A. McTiernan, D. Driver, M. P. Michelagnoli, A. M. Kilby, and J. S. Whelan

High dose chemotherapy with bone marrow or peripheral stem cell rescue is an effective treatment option for patients with relapsed or progressive Ewing's sarcoma family of tumours
Annals of Oncology Advance Access published on June 16, 2006
Ann Oncol 17: 1301-1305; doi:10.1093/annonc/mdl108
[Abstract] [Full Text] [PDF] [Request Permissions]

supportive care:

O. Penack, S. Schwartz, P. Martus, M. Reinwald, M. Schmidt-Hieber, E. Thiel, and I. W. Blau

Low-dose liposomal amphotericin B in the prevention of invasive fungal infections in patients with prolonged neutropenia: results from a randomized, single-center trial
Annals of Oncology Advance Access published on June 9, 2006
Ann Oncol 17: 1306-1312; doi:10.1093/annonc/mdl128
[Abstract] [Full Text] [PDF] [Request Permissions]

phase I and pharmacokinetics:

A. Greystoke, S. Blagden, A. L. Thomas, E. Scott, G. Attard, R. Molife, L. Vidal, S. Pacey, D. Sarkar, A. Jenner, J. S. De-Bono, and W. Steward

A phase I study of intravenous TZT-1027 administered on day 1 and day 8 of a three-weekly cycle in combination with carboplatin given on day 1 alone in patients with advanced solid tumours
Annals of Oncology Advance Access published on May 25, 2006
Ann Oncol 17: 1313-1319; doi:10.1093/annonc/mdl097
[Abstract] [Full Text] [PDF] [Request Permissions]

J. A. Gietema, R. Hoekstra, F. Y. F. L. de Vos, D. R. A. Uges, A. van der Gaast, H. J. M. Groen, W. J. Loos, R. A. Knight, R. A. Carr, R. A. Humerickhouse, and F. A. L. M. Eskens

A phase I study assessing the safety and pharmacokinetics of the thrombospondin-1-mimetic angiogenesis inhibitor ABT-510 with gemcitabine and cisplatin in patients with solid tumors
Annals of Oncology Advance Access published on May 25, 2006
Ann Oncol 17: 1320-1327; doi:10.1093/annonc/mdl102
[Abstract] [Full Text] [PDF] [Request Permissions]

cancer prevention:

H. Bleiberg, P. Autier, F. Huet, A. M. Schrauwen, E. Staquet, T. Delaunoit, A. Hendlisz, C. Wyns, J. M. Panzer, B. Caucheteur, P. Eisendrath, and A. Grivegnée

Colorectal cancer (CRC) screening using sigmoidoscopy followed by colonoscopy: a feasibility and efficacy study on a cancer institute based population
Annals of Oncology Advance Access published on May 25, 2006
Ann Oncol 17: 1328-1332; doi:10.1093/annonc/mdl101
[Abstract] [Full Text] [PDF] [CME/CE] [Request Permissions]

letters to the editor:

M. Berretta, F. Di Benedetto, C. Simonelli, A. Bearz, S. Berretta, D. Maugeri, and U. Tirelli

Multidisciplinary approach in a HIV/HCV-positive patient with liver metastases by colorectal cancer in the HAART era
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 1333-1334; doi:10.1093/annonc/mdl026
[Extract] [Full Text] [PDF] [Request Permissions]

D. Aguiar Bujanda, M. Á. Cabrera Suárez, U. Bohn Sarmiento, and J. Aguiar Morales

Successful recovery after accidental overdose of cyclophosphamide
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 1334; doi:10.1093/annonc/mdl022
[Extract] [Full Text] [PDF] [Request Permissions]

F. Levi, P. Colombo, and C. La Vecchia

Effects of new smoking regulations
Annals of Oncology Advance Access published on February 23, 2006
Ann Oncol 17: 1335; doi:10.1093/annonc/mdl024
[Extract] [Full Text] [PDF] [Request Permissions]

C. Simonelli, R. Talamini, A. Bearz, M. Berretta, S. Spazzapan, P. Monini, C. Sgadari, I. Sartor, B. Ensoli, and U. Tirelli

Interleukin-2 continuous infusion and angiogenesis surrogate markers in metastatic renal cell carcinoma
Annals of Oncology Advance Access published on March 28, 2006
Ann Oncol 17: 1335-1336; doi:10.1093/annonc/mdl043
[Extract] [Full Text] [PDF] [Request Permissions]

M. Ardine, D. Generali, M. Donadio, S. Bonardi, M. Scoletta, A. M. Vandone, M. Mozzati, O. Bertetto, A. Bottini, L. Dogliotti, and A. Berruti

Could the long-term persistence of low serum calcium levels and high serum parathyroid hormone levels during bisphosphonate treatment predispose metastatic breast cancer patients to undergo osteonecrosis of the jaw?
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 1336-1337; doi:10.1093/annonc/mdl045
[Extract] [Full Text] [PDF] [Request Permissions]

L. Mileshkin and J. Zalcberg

The multidisciplinary management of patients with cancer
Annals of Oncology Advance Access published on March 8, 2006
Ann Oncol 17: 1337-1338; doi:10.1093/annonc/mdl046
[Extract] [Full Text] [PDF] [Request Permissions]

To see an article, click its [Full Text] or [PDF] link. To review many abstracts, check the boxes to the left of the titles you want, and click the 'Get All Checked Abstract(s)' button. To see one abstract at a time, click its [Abstract] link.